HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 204 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $304,687 | +12.6% | 10,099 | +25.3% | 0.00% | – |
| Q1 2024 | $270,621 | -3.0% | 8,059 | -6.7% | 0.00% | – |
| Q4 2023 | $279,072 | +780.7% | 8,640 | +793.5% | 0.00% | – |
| Q3 2023 | $31,689 | -67.0% | 967 | -64.5% | 0.00% | – |
| Q2 2023 | $95,927 | +29.9% | 2,726 | +20.6% | 0.00% | – |
| Q1 2023 | $73,821 | -25.9% | 2,261 | +25.0% | 0.00% | – |
| Q4 2022 | $99,676 | +243.7% | 1,809 | +174.5% | 0.00% | – |
| Q3 2022 | $29,000 | +2800.0% | 659 | +2645.8% | 0.00% | – |
| Q2 2022 | $1,000 | -83.3% | 24 | -79.8% | 0.00% | – |
| Q1 2022 | $6,000 | – | 119 | +600.0% | 0.00% | – |
| Q2 2021 | $0 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |